The purpose of this Amendment 001 is to answer the following vendor questions: Q1: We would like to know if this is a brand-new contract OR if there is (was) an incumbent performing these services. A1: This is a continuation of contract 36C25921C0006 and the incumbent is Hyperion Biotechnology . Q2: Combined Synopsis/Solicitation Notice Page 7, Addendum to FAR 52.212-1 Instructions to Offerors Can the government clarify if subparagraphs a-d are required as the Solicitation and SOW are for laboratory analysis services? A2: No, paragraphs a-d will not be required. Q3: SOW Legionella Sampling, Section 5.3 states: If Legionella pneumophila (P) species is detected in the samples, further delineation of serogroup types for positive samples is required. Can the government clarify if delineation of Legionella pneumophila serotypes to serotype 1 and serotypes 2-15 is sufficient or are individual serotypes required (for example Legionella pneumophila serotype 5)? A3: The laboratory to be contracted is to determine if there is legionella in the sample and the level (in cfu/ml) of legionella identified. If so, the laboratory is required to determine if the legionella is pneumophila. If so, the laboratory is required to determine all the serogroups are 1-15 in the sample. If the legionella sample is not pneumophila the laboratory is to identify the legionella species identified in the sample.
